Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taylor Stone

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Cell Reports|February 16, 2022
Balanced T and B cell responses are required for immune protection against Powassan virus in virus-like particle vaccinationE Taylor Stone, Mariah Hassert, Elizabeth Geerling, et al.
Nature Communications|May 6, 2025
Single-dose replicon RNA Sudan virus vaccine uniformly protects female guinea pigs from diseaseKyle L O'Donnell, Hanna Anhalt, Greg Saturday, et al.
Plos Pathogens|December 16, 2020
mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2Mariah Hassert, Elizabeth Geerling, E Taylor Stone, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
mRNA-LNP Vaccines Encoding for Dengue Optimized prM/ENV Proteins Induce Protective Immunity without ADEEnzo LaMontia-Hankin, Clayton J Wollner, E Taylor Stone, et al.
Cell|February 28, 2026
High-resolution in situ structures of hantavirus glycoprotein tetramersLuqiang Guo, Elizabeth McFadden, Megan M Slough, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
High-resolution in situ structures of hantavirus glycoprotein tetramersLuqiang Guo, Elizabeth McFadden, Megan M Slough, et al.
Nature Communications|January 14, 2025
Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in miceDavid W Hawman, Thomas Tipih, Eddie Hodge, et al.
Frontiers in Immunology|September 4, 2023
The role of vaccination route with an adenovirus-vectored vaccine in protection, viral control, and transmission in the SARS-CoV-2/K18-hACE2 mouse infection modelAlexandria Dickson, Elizabeth Geerling, E Taylor Stone, et al.
Frontiers in Immunology|September 23, 2021
The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus DiseaseAmelia K Pinto, Mariah Hassert, Xiaobing Han, et al.
NPJ Vaccines|July 16, 2025
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccineMichael W Crawford, Walid M Abdelwahab, Karthik Siram, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Cell Reports|February 16, 2022
Balanced T and B cell responses are required for immune protection against Powassan virus in virus-like particle vaccinationE Taylor Stone, Mariah Hassert, Elizabeth Geerling, et al.
Nature Communications|May 6, 2025
Single-dose replicon RNA Sudan virus vaccine uniformly protects female guinea pigs from diseaseKyle L O'Donnell, Hanna Anhalt, Greg Saturday, et al.
Plos Pathogens|December 16, 2020
mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2Mariah Hassert, Elizabeth Geerling, E Taylor Stone, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
mRNA-LNP Vaccines Encoding for Dengue Optimized prM/ENV Proteins Induce Protective Immunity without ADEEnzo LaMontia-Hankin, Clayton J Wollner, E Taylor Stone, et al.
Cell|February 28, 2026
High-resolution in situ structures of hantavirus glycoprotein tetramersLuqiang Guo, Elizabeth McFadden, Megan M Slough, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
High-resolution in situ structures of hantavirus glycoprotein tetramersLuqiang Guo, Elizabeth McFadden, Megan M Slough, et al.
Nature Communications|January 14, 2025
Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in miceDavid W Hawman, Thomas Tipih, Eddie Hodge, et al.
Frontiers in Immunology|September 4, 2023
The role of vaccination route with an adenovirus-vectored vaccine in protection, viral control, and transmission in the SARS-CoV-2/K18-hACE2 mouse infection modelAlexandria Dickson, Elizabeth Geerling, E Taylor Stone, et al.
Frontiers in Immunology|September 23, 2021
The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus DiseaseAmelia K Pinto, Mariah Hassert, Xiaobing Han, et al.
NPJ Vaccines|July 16, 2025
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccineMichael W Crawford, Walid M Abdelwahab, Karthik Siram, et al.
Pageof 4